Page 3 - Bill Koschak News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Calyxt, Inc (CLXT) Q3 2022 Earnings Call Transcript

Calyxt, Inc. (NASDAQ:NASDAQ:CLXT) Q3 2022 Earnings Conference Call November 3, 2022 4:30 PM ET Company Participants William Koschak - CFO Michael Carr - President and CEO Presentation.

United statesCanaccord genuityMichael carrWilliam koschakMichaela carrCompany participantsCalyxt incConference call novemberCalyxt third quarterCorporate update conference callBill koschakCalyxt chief financialChief financial officerChief executiveInvestor relationsCalyxt engineered plant cell matrix

Calyxt Reports Third Quarter 2022 Financial Results and Provides Corporate Update

Successfully produced squalene, an important ingredient for personal care products and vaccine adjuvants Continued to progress customer acquisition.

United statesCanaccord genuityKimberly minarovich cameron willisGerry nuovoBrennan burksMichaela carrCalyxt incTechnology platformCurrent customer projects under developmentChemistries under development for potential customersCalyxt business development contactPayroll protection programToll internationalCompany biofactoryScale of calyxt proprietary technologyBusiness development

Calyxt to Host Third Quarter 2022 Financial Results Conference Call and Webcast on Thursday, November 3, 2022, at 4:30 p m Eastern Time

Calyxt to Host Third Quarter 2022 Financial Results Conference Call and Webcast on Thursday, November 3, 2022, at 4:30 p m Eastern Time
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Kimberly minarovich cameron willisBrennan burksMichaela carrPrnewswire calyxt incToll internationalCalyxt incInternational replay numberChief executive officerChief financial officerBill koschakFree replay numberReplay numberPlant cell matrixMedia contactInvestor relations contact

Calyxt to Present at the H C Wainwright 24th Annual Global Investment Conference

/PRNewswire/ Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biology company, today announced that Michael A. Carr, President and Chief Executive.

Kimberly minarovich cameron willisBrennan burksMichaela carrCalyxt incChief executive officerBill koschakChief financial officerAnnual global investment conferencePlant cell matrixMedia contactInvestor relations contact

Calyxt Reports Second Quarter 2022 Financial Results and Provides Corporate Update

Evaluated nine new customer demand-driven plant-based chemistries in the quarter, bringing cumulative chemistries evaluated for development to 95, of these 31.

United statesCanaccord genuityKimberly minarovich cameron willisGerry nuovoMichaela carrCalyxt incTechnology platformChemistries under development for potential customersCalyxt business development contactPayroll protection programToll internationalCompany biofactoryPete ball as technology licensing leaderTerm sheets for licensing of technologyChief executive officerMultiple global infrastructure partners underway